SOURCE: Leerink Swann & Company

July 15, 2005 06:00 ET

Leerink Swann & Company Initiates Coverage of Barrier Therapeutics, Inc. (NASDAQ: BTRX)

BOSTON, MA -- (MARKET WIRE) -- July 15, 2005 -- Yesterday after the close, Senior Specialty Pharmaceuticals Analyst, Gary Nachman, initiated coverage of Barrier Therapeutics, Inc. with a Market Perform rating. While MEDACorp consultants confirm Mr. Nachman's assessment of Barrier's robust product pipeline in dermatology, he bases his investment rating on his belief that Barrier's stock price will be range bound in the near to medium term because two recent product setbacks have heightened the risk profile for the company and because he sees no meaningful catalysts for the next six to nine months.

About Barrier Therapeutics, Inc.

Barrier Therapeutics, Inc. (NASDAQ: BTRX) is a pharmaceutical company focused on the discovery, development and commercialization of dermatology products. Barrier markets Solage in the U.S. and Canada and has eight product candidates in its pipeline. Its four most advanced product candidates are Zimycan™, Sebazole™, Hyphanox™ and Liarozole™. The company is headquartered in Princeton, New Jersey.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564